Market data shows that global sales of cardiovascular devices are expected to exceed $110 billion by 2029. Among them, the market growth rate in the Asia Pacific region is leading, and it is expected that the sales revenue will reach 27.5 billion US dollars in 2029, with an average annual compound growth rate of 8.85%. The Chinese cardiovascular interventional medical device market has shown outstanding performance, and it is expected that the market sales will exceed 90 billion yuan by 2026 At present, the cardiovascular intervention diagnosis and treatment technologies carried out in China include coronary angiography, intravascular ultrasound, percutaneous coronary balloon angioplasty, interventional treatment of chronic occlusive disease with CTO, pacemaker implantation, etc. In order to promote the development of cardiovascular intervention and technology, the Shenzhen Medical Association and Shenzhen Juyi Exhibition Service Co., Ltd. jointly organized the 2025 Shenzhen International Cardiovascular Intervention and Technology Exhibition, which will be held at the Shenzhen International Convention and Exhibition Center. At the same time, the Shenzhen International Cardiovascular Disease Academic Conference will be organized. We sincerely invite you to participate! Exhibition Consultation Hotline: 18964878976 Yang Hao (Sales Director)